Melanie Rupert

Practice Areas

Melanie Rupert is a partner in Paul Hastings’ Life Sciences IP group, where her practice focuses on patent litigation matters, with an emphasis on the biotechnology, pharmaceutical, and medical device industries.

She has more than two decades of experience in the life sciences space, including significant experience leading Hatch-Waxman cases on behalf of innovators, and has represented some of the world’s leading life sciences companies in high-stakes patent challenges to their blockbuster products. In addition, Melanie guides clients on strategic matters related to patent portfolio development, post-grant review challenges, and ex-U.S. opposition proceedings. She also partners with clients in due diligence analysis related to company and product-based asset acquisitions.

Melanie is significantly involved in internal and external initiatives to improve inclusion in the legal profession while holding several leadership roles at Paul Hastings, including serving as the global co-chair of talent development. She frequently speaks and writes about current issues in the life sciences industry. She also served as an adjunct professor at NYU School of Law, where she taught a course on life sciences patent law each spring. She is recognized by leading directories, including Chambers USA, which states, “Melanie is incredibly smart and strategic,” and “She is phenomenal and is a really tough opponent; her depth of knowledge and skill is second to none.”